🇺🇸 FDA
Pipeline program

Placebo is a solution for infusion of human albumin 1%, is an albumin preparation manufactured by dilution from the drug product of Albiomin 20%, it will be administrated via intravenous infusion., Trimodulin (human IgM, IgA, IgG solution)

1001

Phase 3 small_molecule active

Quick answer

Placebo is a solution for infusion of human albumin 1%, is an albumin preparation manufactured by dilution from the drug product of Albiomin 20%, it will be administrated via intravenous infusion., Trimodulin (human IgM, IgA, IgG solution) for Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19) is a Phase 3 program (small_molecule) at Biotest Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotest Pharma GmbH
Indication
Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials